Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J López Pascual

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Sangre|February 1, 1988
[Occurrence of indirect markers of non-A, non-B hepatitis (increased anti-HBc -HBV and -ALT) in altruistic blood donors]J López Pascual
Revista Clinica Espanola|April 1, 1988
[Prognostic factors in myeloma]J López Pascual, J M Fernández-Rañada
Revista Clinica Espanola|April 1, 1988
[Renal function in multiple myeloma. Critical analysis of its prognostic value]J López Pascual, J M Fernández Rañada
Revista Clinica Espanola|September 30, 1983
[Therapeutic plasmapheresis]J López Pascual, A Puras Tellaeche, J Montero Castillo
Medicina Clinica|November 14, 1987
[Evaluation of the prognostic significance of renal insufficiency in myeloma. Multivariate analysis]J López Pascual, F García Ahumada, J M Fernández Rañada
Revista Clinica Espanola|April 1, 1987
[Prognostic factors in myeloma. Step-by-step regression analysis (Cox method)]J López Pascual, F García Ahumada, J Montero, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Acute leukemia in multiple myelomaJ Feliu, M Pérez Sánchez, J López Pascual, et al.
Sangre|January 1, 1975
[Plasma cell leukaemia. Haematological features and response to treatment (author's transl)]J M Fernández Rañada, C Ribera, J López Pascual, et al.
British Journal of Haematology|May 1, 1990
Is the newly proposed prognostic system for multiple myeloma useful?J M Montera Garcia, J Felin, A Artal, et al.
Bone Marrow Transplantation|February 2, 1997
Results of a pilot study of 40 patients using high-dose therapy with hematopoietic rescue after standard-dose adjuvant therapy for high-risk breast cancerJ F Tomás, R Pérez-Carrión, A Escudero, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Sangre|February 1, 1988
[Occurrence of indirect markers of non-A, non-B hepatitis (increased anti-HBc -HBV and -ALT) in altruistic blood donors]J López Pascual
Revista Clinica Espanola|April 1, 1988
[Prognostic factors in myeloma]J López Pascual, J M Fernández-Rañada
Revista Clinica Espanola|April 1, 1988
[Renal function in multiple myeloma. Critical analysis of its prognostic value]J López Pascual, J M Fernández Rañada
Revista Clinica Espanola|September 30, 1983
[Therapeutic plasmapheresis]J López Pascual, A Puras Tellaeche, J Montero Castillo
Medicina Clinica|November 14, 1987
[Evaluation of the prognostic significance of renal insufficiency in myeloma. Multivariate analysis]J López Pascual, F García Ahumada, J M Fernández Rañada
Revista Clinica Espanola|April 1, 1987
[Prognostic factors in myeloma. Step-by-step regression analysis (Cox method)]J López Pascual, F García Ahumada, J Montero, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Acute leukemia in multiple myelomaJ Feliu, M Pérez Sánchez, J López Pascual, et al.
Sangre|January 1, 1975
[Plasma cell leukaemia. Haematological features and response to treatment (author's transl)]J M Fernández Rañada, C Ribera, J López Pascual, et al.
British Journal of Haematology|May 1, 1990
Is the newly proposed prognostic system for multiple myeloma useful?J M Montera Garcia, J Felin, A Artal, et al.
Bone Marrow Transplantation|February 2, 1997
Results of a pilot study of 40 patients using high-dose therapy with hematopoietic rescue after standard-dose adjuvant therapy for high-risk breast cancerJ F Tomás, R Pérez-Carrión, A Escudero, et al.
Pageof 2